Infusive US Trust - Infusive Compounding Global Equities ETF Overview

Infusive US Trust - Infusive Compounding Global Equities ETF Cost of Revenue

Cost of Revenue analysis for JOYY.

Quarterly Cost of Revenue

$366.40M

↑ 16.05% YoY

As of Mar 31, 2026

Annual Cost of Revenue (TTM)

$1.41B

↑ 2.63% YoY

Trailing 12 months ending Mar 31, 2026

Average Cost of Revenue (Comparison Companies)

Cost of Revenue History

Cost of Revenue Comparison

Annual Cost of Revenue Growth Rate (%)

Annual Cost of Revenue Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin